Executive Interview with Jon Albrecht, Methodist Health System

Pharmacy Angle had the opportunity to sit down with Jon Albrecht, Vice President & Chief Pharmacy Officer for Methodist Health System while at the Health Connect Partner's Pharmacy Conference in Indianapolis to get his thoughts on challenges and trends across the industry. 

Jon, based in Dallas, Texas, is responsible for thirteen hospitals, two retail pharmacies, about thirty to thirty five, clinics...all told about seventeen hundred beds. On the way to the top of his profession, Jon has seen what beinga pharmacy leader means and requires while also witnessing the roller coast that is manpower and staffing. Jon talks about the changes that are necessary to recruit pharmacy technicians in today's work force, drug shortages, and much more. 

 

Latest Videos
View all Videos
Executive Insights
Feb 25, 2025
Hinnah Farooqi serves as the Director of Pharmacy at New York Presbyterian in Queens, a diverse hospital with 500 beds. She discusses the hospital's efforts to improve efficiency and patient safety by using more automation, like RFID technology called Intelligard. Hinnah also emphasizes teamwork with the central sterile team and the hospital's focus on developing leaders and improving management skills through partnerships and internal programs.
Feb 25, 2025

Valerie Hoffman is the Associate Marketing Director at Long Grove Pharmaceuticals. Valerie prioritizes drug safety and aims to enhance it through clear, distinctive labeling. She also emphasizes open communication in leadership and works to build strong customer relationships. 

Executive Insights
Feb 10, 2025

Mark Saxon, the CEO of Safecor Health, discusses the company's strategic plans for 2025, emphasizing their commitment to unit dose drug repackaging and error-free medication delivery. Mark highlights the importance of cultural change and core values such as care, commitment, and excellence in leadership. He expresses excitement about tackling healthcare challenges, cherishes family traditions, and is looking forward to a successful 2025.